Clinical trial
A Randomized Controlled Trial of a Weekly Schedule of Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment (5/2 Intermittent Treatment Schedule) Versus Continuous Treatment in Individuals With Virologic Suppression on This Combination
NCT00414635 is registered in ClinicalTrials.gov with Community Research Initiative of New England as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of a Weekly Schedule of Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment (5/2 Intermittent Treatment Schedule) Versus Continuous Treatment in Individuals With Virologic Suppression on This Combination
- Lead sponsor
- Community Research Initiative of New England
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2006
- Completion date
- December 31, 2009
- Enrollment
- 60 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.